These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 8694533

  • 1. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE, Cracchiolo BM, Cole LA.
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [Abstract] [Full Text] [Related]

  • 2. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, Chambers JT, Nam JH.
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
    Walker R, Crebbin V, Stern J, Scudder S, Schwartz P.
    Anticancer Res; 1994 Feb; 14(5A):1703-9. PubMed ID: 7847804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. UGP in urogenital disorders: Egyptian experience.
    el-Ahmady O, Halim AB, Gad M, Walker R.
    Anticancer Res; 1996 Feb; 16(4B):2301-8. PubMed ID: 8694560
    [Abstract] [Full Text] [Related]

  • 9. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
    Plebani M, Navaglia F, Basso D, De Paoli M, Nicoletto MO, Maraglino E, Torre GC.
    Anticancer Res; 1996 Feb; 16(6B):3833-8. PubMed ID: 9042266
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D, Hirasawa A, Susumu N.
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [Abstract] [Full Text] [Related]

  • 11. Chronobiologic aspects of urinary gonadotropin peptide (UGP).
    Cornélissen G, Halberg F, Walker R, Zaslavskaya RM, Fine RL, Haus E.
    In Vivo; 1995 Mar; 9(4):359-62. PubMed ID: 8555435
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
    Mayerhofer K, Bodner K, Aktas C, Schindl M, Kaider A, Leodolter S, Joura EA, Kainz C.
    Anticancer Res; 2000 Mar; 20(2B):1281-4. PubMed ID: 10810435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.